Avenue Therapeutics Inc

NASDAQ:ATXI   2:03:27 PM EDT
1.59
-0.07 (-4.22%)
Products

Avenue Therapeutics Inc - On August 26, Co Received An Appeal Denied Letter From Office Of Neuroscience Of FDA

Published: 08/27/2021 13:32 GMT
Avenue Therapeutics Inc (ATXI) - Avenue Therapeutics Inc - on August 26, Co Received an Appeal Denied Letter From Office of Neuroscience of FDA.
Avenue Therapeutics Inc - Intends to Continue to Pursue Regulatory Approval for Iv Tramadol.
Further Company Coverage: Atxio (((reuters.
Briefs@thomsonreuters.
Com);)).